
Sign up to save your podcasts
Or


On this week’s Tech Nation, Moira speaks with Dr. David Bearss, President and CEO of Halia (Hah-lee-ah) Therapeutics, about their groundbreaking work, both in inflammation and in another drug to potentially resist Alzheimer’s. Then, Melissa Sevigny (Sev-inn-nee), Science Journalist and Author of “Brave the Wild River: The Untold Story of Two Women Who Mapped the Botany of the Grand Canyon”.
By Tech NationOn this week’s Tech Nation, Moira speaks with Dr. David Bearss, President and CEO of Halia (Hah-lee-ah) Therapeutics, about their groundbreaking work, both in inflammation and in another drug to potentially resist Alzheimer’s. Then, Melissa Sevigny (Sev-inn-nee), Science Journalist and Author of “Brave the Wild River: The Untold Story of Two Women Who Mapped the Botany of the Grand Canyon”.